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ABSTRACT 
 
Introduction   
Diabetes related peripheral neuropathy is a major etiological factor in the 
development of neuropathic foot ulcers.  Repeated trauma and pressure on the 
ulcer bed are the two main reasons for persistence of ulcer. 
Offloading allows for pressure relief at areas of high pressure thus facilitating 
healing process of foot ulcers.  It is suggested that “Pressure relief on ulcers 
commonly referred to as offloading should always be a part of the treatment plan” 
Cavanagh et al (2005)  
 
Aims and Objectives 
The objective of this study is to compare the effectiveness of removable (custom 
made shoes) and irremovable (total contact cast) devices to offload plantar diabetic 
ulcers.  The following aspects of offloading are looked upon: 
1) wound surface areas reduction 
2) number and severity of adverse events 
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Materials and Methods 
Diabetic foot ulcer patients who have been admitted or have visited PSG hospital 
on OP basis were included in the study.  32 of these patients, who met inclusion 
and exclusion criteria of the study, formed the study population.  After a detailed 
history, examination and necessary investigations, ulcers were surgically debrided 
to remove non viable tissues.  Ulcers were photographed and measured and 
offloading devices were applied. Patients were advised 2 weekly follow-up for the 
next 3 months.  The outcome was studied based on ulcer size reduction and the 
presence or absence of adverse events. 
 
Results  
A total of 32 patients were included in the study.  Two patients in the TCC group 
and one patient in the custom made shoe group failed to complete the study.  The 
ulcer surface area decreased from 6.82 cm
2
 - 1.34cm
2
 in TCC group and from 5.86 
cm
2 
- 2.23 cm
2 
in custom made shoe group.  Higher proportions of patients were 
healed by 12weeks in TCC group when compared to custom made shoe group. 
(1.34cm
2
, P value=0.0154, Vs 2.23cm
2
, P value=0.0016).  Eleven out of the sixteen 
patients (68.7%) in TCC group had achieved complete healing with 90days of 
13 
 
treatment, of which 5 patients  healed between 42 to 70days and three out of the 
thirteen patients (23%) had attained complete healing in custom made shoe group 
at the end of 12 weeks.  The mean number of days for the ulcer to heal in the TCC 
group was 66.63 days whereas in the custom made shoe group it was 83.23 days 
which infers that the mean duration of healing time was less with TCC than with 
custom made shoes. 
 
Conclusion  
TCCs are gold standard in offloading diabetic foot ulcers with high proportion of 
healing rates in lesser amount of time compared to custom made shoes. 
 
Keywords:  Diabetes melliteus, neuropathy, plantar ulcers, off-loading, Total 
contact Cast 
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INTRODUCTION 
 
Diabetic neuropathic ulcers are the most frequent form of ulcers in the foot
1
.  
These ulcers are the major determinant of diabetes-related amputations of lower 
extremity
1
.  About 85% of all the amputation in diabetes is mostly preceded by an 
ulcer
1
. 
Excessive pressure on sole of these neuropathic feet is the cause for developing 
these ulcers.  The key to effective healing of these ulcers is to provide complete 
relief of pressure (off-loading) at the site of theses ulcers
2
.  „Offloading  is a pivotal 
but often ignored and neglected aspect of wound care‟- highlighted by Lavery 
(2003). 
 
Along with pressure relief, surgical debridement of the ulcer and adequate dressing 
of the wound is essential for the complete healing of these ulcers
3
.  Compliance of 
patients is generally poor as these patients lack any symptoms due to sensory 
neuropathy and tend to wear off-loading device very rarely
4
.  
   
Hence, a multidisciplinary team is needed which includes physicians for strict 
diabetic control, surgeons in assessment of wound condition and need for 
16 
 
debridement, podiatrist in assessing neuro-ischemic status of foot and a technician 
in off-loading of the ulcer. This team approach helps in effectively treating diabetic 
foot wounds.   
The treatment most commonly employed in pressure reduction at the ulcer site of 
the foot are either a removable therapeutic shoe or an irremovable total contact 
cast
5
. 
Therefore the purpose of this study was to compare effectiveness of removable and 
irremovable off-loading device to heal neuropathic foot ulceration in diabetic 
patients. 
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Aims and Objectives 
 
The objective of this study is to compare the effectiveness of removable (custom 
made shoes) and irremovable (total contact cast) devices to offload plantar diabetic 
ulcers. Also the following aspects of offloading are looked upon: 
1) wound surface areas reduction 
2) number and severity of adverse events 
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Review of Literature 
History 
 
1.1 History of Diabetes 
Diabetes mellitus is one of the many common diseases known to affect the 
mankind from antiquity
6
.  Its history started approximately in 1550BC
7
.  An 
ancient literature of Egyptian medical journal has recorded it as a disease causing 
the patient to lose weight rapidly “Too great emptying of urine” 7.  
 
Indian physician at the same time identified the sweetness of urine by noting that 
the urine would attract ants and classified it as madhumeha or “honey urine” 7.  It 
is the Greeks (Apollonius of Memphis) in 230BC who termed it “diabetes” or “to 
pass through” 7.  The word “mellitus” comes from Latin word meaning sweetened 
with honey.  It was in 1675 when Thomas Willis added mellitus to the word 
diabetes as a designation for the disease
7
. 
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Other historic milestones in diabetes are as follows: 
 Greek physician Aretaeus of Cappadocia in 2nd century AD noticed the 
excess amount of urine being passed through the kidneys also was able to 
distinguish between Diabetes Melliteus and Diabetes insipidus
8
.
.
 
 
 Aretaeus and Galen Roman physician attributed development of Diabetes to 
weakness of kidneys and called it “diarrhea of urine” (diarrhea urinosa) 9. 
 
 5th century AD, Sushrutha and Charaka, two Indian physicians 
differentiated between two types of diabetes: Type1 diabetes is seen in 
youths and Type2 diabetes in obese individuals
8
. 
 
 An important milestone in history of diabetes is establishment of role of 
liver in glycogen and the fact that diabetes is due to excess glucose 
production – Claude Bernard in 1857 10. 
     
 Avicenna (980-1027)AD gave good description of diabetes and its 
complications and diabetic gangrene
8.
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  Mathew Dibson (1713-1784) proved the sweetness of urine is due to sugar 
and established sweetness of serum as hyperglycemia.  He suggested that 
diabetes mellitus is a systemic disease
9
.  
 
 Pyrce (1887) described association of foot ulcer, neuropathy and vascular 
disease with diabetes mellitus
11
. 
 
 In 1900, the exact link between pancreas and diabetes was established 11. 
 
 Charles Best and Fredrick Banting (1922-1936) discovered insulin from 
pancreas
12
. 
 
 Able (1926) prepared crystalline insulin. 
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1.2 History of diabetic foot ulcer 
Foot ulceration is the most common and disabling complication of diabetes 
mellitus.  From ancient days, diabetes is a disease characterized by wide range of 
complications of which foot ulceration can lead to significant disability including 
lower extremity amputations
13. 
 
Between 1850 and 1870, plantar ulcers and gangrene were recognized as 
complications of Diabetes
11
.  In 1798, John Rollo noticed that diabetic patients had 
difficulty in using their limbs due to pain and paraesthesia of lower limbs
11
.  
In earlier days all cases were described as “diabetic gangrene”. 
 Nitch in 1923 regarded it as senile gangrene due to arteriosclerosis11. 
 Rose and Carless, a decade later recognized the etiology as peripheral 
neuritis and endarteritis. 
 Aird in 1957 identified the importance of infection in young patients. 
 In 1893, a distinction was found between gangrene due to vascular 
insufficiency and gangrene due to infection in a limb with normal blood 
supply. 
 
24 
 
During this time, the only treatment was major amputation of the limb even if the 
area of gangrene was small 
11
. 
 
It was regarded that diabetic foot occurred as a result of infection and pressure 
necrosis of soft tissue which was compressed between callosity of the sole and 
head of metatarsal bone leading to poor wound healing 
14
.  Also some patients had 
clawing of foot where the metatarsal heads showed abnormal descent and toes had 
become hyper extended.  60% of patients with previous ulcer history have chance 
of developing another ulcer over the same area because the skin over the healed 
ulcer site will be less resilient to accept repetitive stress.  Hence they are more 
prone to subsequent ulcer
15
.  
 
1.3 History of treatment of diabetic foot ulcer 
In yester years, the final outcome of complications of diabetic foot was invariably 
amputation
16
.  Even now the cause for inpatient occupancy in diabetic patients is 
due to foot problems rather than the any other medical complications of diabetes
16
. 
Before the Second World War, the gangrenous changes in diabetic foot were 
considered due to a single cause and later, only in 1893; a distinction was found in 
25 
 
gangrene due to vascular insufficiency and gangrene due to infection in a limb with 
normal blood supply
11
. 
 
Diabetic foot ulcer healing seems to be arrested at inflammatory or proliferative 
process, causing infection and inflammation.  Many years ago honey was used in 
dressing of diabetic foot ulcer
17
.  It was found that the anti inflammatory action of 
honey would decrease the excess activity of collagenase and elastase which are 
seen in inflammatory condition.  It was observed that honey promotes tissue 
regeneration by stimulating angiogenesis and growth of fibroblasts and epithelial 
cells
17
. 
 
For the past 40 years, the concept of moist wound healing of diabetic ulcers has 
been accepted.  
The various types of moist wound dressing are: 
Calcium alginate dressings: These are dressings derived from seaweed available as 
sheets to pack deep wounds.  The exudates from the wound and calcium alginate 
form a gel. These are used for moderate to heavy draining wounds. 
26 
 
Collagen dressings: These are used for moderate to heavily draining wounds to 
enhance healing and tissue repair.  These have been found useful on burns, 
pressure ulcers and dermatologic conditions. 
 
Foam dressings: They are made of hydrophilic polyurethane foam, and offer a 
moist environment and cushion the wound.  
 
Hydrocolloid dressings: These are soft wafers which become gel like when in 
contact with wound exudates.  They are waterproof and impermeable to bacteria 
and dust. 
 
Hydrogels: They hydrate tissue and facilitate debridement using the body‟s own 
enzymes.  Because of high water content, there is limited drainage.   
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2. Extent of the problem 
 
2.1 Globally 
It has been estimated that, the number of people having diabetes mellitus 
worldwide was 131 million in 2000 and it is projected to increase to 366 million by 
2030 
18
.  4%-10% of pts with diabetes have a risk of developing foot ulcer at 
anytime in their life
19
.  The annual incidence of diabetic foot ulcer is about 3% and 
the incidence in U.S and U.K ranges as 10% 
20
.  Lower extremity diseases affect 
30% of diabetic persons who are older than 40 years
21
.  Peripheral arterial disease, 
peripheral neuropathy, foot ulceration, or lower extremity amputation, is twice as 
common in diabetic persons compared with non-diabetic persons
21
.  Almost 40% 
of this amputation can be avoided if there is a team approach to care of diabetic 
wound.  The incidence of amputation can be reduced if the incidence of diabetic 
foot ulcer reduces. 20% of diabetic patients with foot ulcer have peripheral arterial 
disease about 50% have peripheral neuropathy and 30% will have a combination of 
both
22
.  The estimated costs of treating a diabetic foot ulcer were $28,000 in a 1999 
US study
23
, and $18 000 (with no amputation) and $34 000 (with amputation) in a 
2000 Swedish study.
24   
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2.2 India  
India has the largest diabetes population in the world.  More than 50million people 
are diagnosed to have diabetes.  85% of amputated cases have found to have 
diabetes as the causal factor.  The prevalence of amputation is about 3%. In India 
the prevalence of diabetic foot complications like neuropathy is 15%, peripheral 
vascular disease is 5% and infections is 7.6%.  55% of foot ulcers are neuropathic, 
35% are neuroischemic and 10% are ischemic.  Diabetic foot ulcers cause a huge 
amount of emotional, physical, productivity and financial losses
25
. 
.
  
 
 
Pathogenesis of diabetic foot ulcer 
 
Patients with diabetes have 12-25% lifetime risk of developing a foot ulcer
26
. 
People with diabetes mellitus develop foot ulcer due to neuropathy (sensory, 
motor, and autonomic), ischemia or both
27
.  Hence these ulcers are classified into 
neuropathic, ischemic, or neuroischemic.  But there is a complex interplay between 
these factors and other etiological factors like increased foot pressures, limited 
joint mobility, poor glycemic control, and cardiovascular parameters
27
.  Hence 
29 
 
identifying these high risk patients and educating them will help us in reducing the 
incidence of foot ulcerations and amputations
27
. 
Diabetes mellitus primarily affects the vessels & nerves causing vasculopathy and 
neuropathy. 
 
Vasculopathy 
Atherosclerotic vascular disease is present in subclinical form in diabetic patients 
with long duration
27
.  One of the earliest steps in the pathogenesis of 
atherosclerosis is the binding of monocytes, leukocytes, and platelets to the 
endothelium which is promoted by adhesion molecules.  Such adhesion molecules 
are seen to be elevated in diabetes
28
.  Peripheral vascular disease was found to be 
2.5 to 3 times commoner in diabetic than nondiabetic patients
29
. 
 
Peripheral vascular disease in diabetes mainly effects the vessels between knee and 
ankle (infra popliteal) leading to poor perfusion of tissues causing friable tissues 
27
. 
Thus a mechanical damage to these tissues leads to development of ischemic 
ulcers.  In 38-52% of ulcers, ischemia is the major etiological factor and 46% of 
amputations are due to ischemia
30
.  Thus any form of injury leads to increased 
30 
 
requirement of blood supply which cannot be met leading to ischemic ulcerations 
and risk of amputation follow
30
. 
 
Neuropathy  
The incidence of neuropathy is equal to the duration and severity of 
hyperglycemia.  Patients with neuropathy are at 1.7times greater risk for ulceration 
compared to patients without neuropathy
31
. 
 
Causes of neuropathy: 
There are 2 theories to causation of diabetic peripheral neuropathy.  First, a 
metabolic factor has been hypothesized as the cause, and the other its association 
with micro vascular disease.  Therefore a nerve biopsy in diabetic neuropathy 
shows both focal nerve fiber loss along with ischemic injury. 
 
Pathophysiology of diabetic neuropathy
32,33
 
1) Hyperglycemia – increased levels of intraneural sorbitol and fructose which 
is toxic to the tissues. 
31 
 
2) Hyperosmolality causing edema of nerves. 
3) Reduced myoinositol- impairs action of Na- K ATPase and altered myelin 
synthesis. 
4) Occlusive vasanervorum 
 
Effects of neuropathy: 
Neuropathy affects the foot both extrinsically and intrinsically. 
1. Extrinsic neuropathic foot ulceration 
Due to loss of somatic sensation over the plantar aspect of the foot, the patient is 
unable to perceive the normal painful stimulus.  The patient‟s perception of touch, 
deep pressure, temperature and joint position is impaired.  Thus a continuous 
tissue-damaging excess mechanical load to an insensate foot leads to ulcer 
formation
34,35
. 
 
              2.   Intrinsic neuropathic foot ulceration 
Somatic motor neuropathy leads to weakness of intrinsic muscles of foot, leading 
to abnormal movement of small bones of the foot along with joint subluxation
27
. 
There is also weakness of foot ligaments due to abnormalities of collagen 
32 
 
metabolism.  Visceral sensory neuropathy leads to reduced proprioception and the 
patient continues to walk.  The ligaments and joint capsule are further stretched 
and bony structure of foot is distorted leading to deformities like claw foot with 
prominent metatarsal heads, or rocker-bottom foot with collapse of longitudinal 
arch and prominence of tarsal bones.  These bony changes produce areas of 
localized high pressure in the sole of the foot mainly metatarsal heads, tips of toes 
and heel
35
.  It initially responds to the high pressure by forming a protective callus 
and a continued shear force traumatizes the underlying subcutaneous tissue 
producing cavities containing blood or serum. Finally the callus breaks down 
resulting in an ulcer
35
.  The typical feature of neuropathic ulcer is that there will be 
deep tissue destruction before the epithelial breakdown. 
 
Other risk factors for development of foot ulcers include: 
1) Previous foot ulceration:  Foot ulcers are more common in those patients with a 
past history of ulceration or amputation and in patients with a poor social 
background. 
33 
 
2) Diabetes duration and control:  Poor glycemic control as measured by HbAlc, 
fasting blood glucose, and even single random blood glucose is strongly 
predictive of subsequent amputation
36
. 
3) Delayed wound healing:  In diabetic patients, the process of wound healing is 
slow and this increases the susceptibility to infection and finally predisposes to 
amputation
37
.  In diabetic patients, neutrophil function is impaired leading to 
abnormalities in phagocytosis and killing ability
37
.  
Characteristics of diabetic foot ulcer 
Diabetic foot ulcers are most commonly seen over the bony prominences and on 
the heel.  Diabetic foot ulcers are classified into two, ischemic and neurotrophic 
based on their ulcer characteristics.  This classification is important in selecting the 
appropriate treatment of ulcer. 
1) Ischemic ulcers:  The ulcer has punched out necrotic areas with sharp 
margins.  During debridement there will be bleeding from the periphery.  
There will be severe pain which is exacerbated during nights.  Relief from 
pain is obtained on hanging the legs down.  Prognosis for healing is poor.  
Treatment includes meticulous foot care and to control risk factors. 
34 
 
2) Neurotrophic ulcers:  These are caused by pressure on the weight bearing 
areas.  The ulcer has granulation surrounded by hyperkeratotic tissue.  Good 
vascular supply is present so the foot is often warm.  Callus with bony 
deformities do occur. 
 
Classification system for Diabetic Foot Ulcers 
Wagner’s Classification for Diabetic Foot Ulcers 
 
Grade Lesion 
1 Superficial diabetic ulcer 
2 Ulcer extension involving, ligaments, tendon, joint capsule, or fascia 
with no abscess or osteomyelitis 
3 Deep ulcer with abscess or osteomyelitis 
4 Gangrene to portion of fore foot 
5 Extensive gangrene of foot 
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University of Texas Diabetic Wound Classification System 
 
Stage  Grade 
 0 I II III 
A (no infection 
or ischemia) 
Pre or post 
ulcerative lesion 
completely 
epithelialised 
Superficial 
wound not 
involving tendon, 
capsule or bone. 
Wound 
penetrating to 
tendon, capsule 
or bone. 
Wound 
penetrating to 
bone or joint. 
B Infection Infection Infection Infection 
C Ischemia Ischemia Ischemia Ischemia 
D Infection and 
Ischemia 
Infection and 
Ischemia 
Infection and 
Ischemia 
Infection and 
Ischemia 
 
 
Treatment of diabetic foot ulcer  
 
The main principle of neuropathic diabetic foot ulcer includes controlling of 
infection and to remove the pressure from the ulcer
38
. 
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Strategies for saving the diabetic foot include
38
: 
1) Tight glycemic control 
2) Identifying etiological factors 
3) Assessment of vascular status 
4) Management of infection 
5) Offloading strategies 
6) Multidisciplinary team approach 
7) Patient education 
 
Glycemic control
 
Adequate glycemic control is the most vital in healing of diabetic foot ulcers.  It 
has been found that leukocyte function is impaired in patients with chronic 
hyperglycemia leading to delay in wound healing of established foot ulcers
38
.  
Identifying the etiological factors 
Foot ulcers are commonly seen in 50% of patients more than 60years
39
. 
The cause for the ulcer, if due to peripheral neuropathy or peripheral vascular 
disease must be identified.  Other causative factors include repetitive trauma, self 
37 
 
inflicting trauma while cutting toe nails, history of previous foot ulcers and 
excessive plantar pressure due to foot deformities
39
.  
Basic examination of foot helps to determine the neuro-vascular status of the foot. 
 
Assessment of vascular status 
Palpation of foot pulses (Dorsalis pedis and posterior tibial artery) would be part of 
the initial examination. 
If pulses are feeble or not palpable, vascular investigations are done to evaluate the 
extent of vaso-occlusion and to assses the healing potential of foot ulcer
40
. 
 
These include: 
1) Doppler study (Duplex scanning with ultrasound analysis) 
 To measure segmental systolic pressure 
 To provide flow velocity wave form. 
 To study the location and amount of lumen occlusion. 
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2) Ankle-Brachial pressure index40 
The higher systolic pressure at the ankle is divided by the brachial pressure 
to give ankle-brachial pressure index (ABPI).  Low values are obtained 
when there is a complete occlusion and high values when there are very 
minimal atheromatous changes.  If there is a constant decrease in ABPI 
means there is an advancing disease and a constant rise in ABPI indicates 
development of collaterals. 
 
3) Toe Pressure 
Toe pressure measurement is reliable in assessing the healing potential of an 
ulcer.  Transducers are inserted in the sole of footwear to assess the toe 
pressure.  In toe pressure >40mmhg, ulcers heal well. If pressure <20mmhg 
healing is doubtful
41
. 
 
4) Transcutaneous oxygen tension (TcPO2) 
Transcutaneous oximetry can be used to measure the arterial oxygen supply. 
>30mmhg - good healing,  <10mmhg – non-healing42. 
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5) Digital subtraction angiography (DSA)43 
Vessels are visualized using digital fluorography technique for image 
enhancement. 
Advantage: 
 DSA accomplishes significantly better contrast resolution. 
 Highly sensitive screening technique for carotids and lower limb vessels. 
 When compared to conventional angiography, cost is less. 
 DSA can be performed routinely on OP basis. 
 DSA may demonstrate small reconstituted vessels distal to an obstruction 
not seen on a catheter cut-film study. 
 
An ideal angiography should answer 4 vital questions: 
1. The site and extent of the stenosis / occlusion. 
2. The „Run-in‟ state of arteries proximal to stenosis is normal or not? 
3.  The „Run-off‟ Arterial bypass surgery is only feasible if a named distal 
artery is open beyond the block. 
4. State of collateral circulation. 
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Neurological assessment of foot
44 
1. Monofilament test: Using 5.07 Semmes-Weinstein monofilament (10gm) 
wires for sensory examination.  
2.  Plantar pressure: Assessed using Harris mat and computer technique. 
Allows quantitative measurements of plantar foot pressure. 
3. Two point discrimination 
4. Vibration sense 
5. Temperature sensation 
 
Control of wound infection 
Early identification of infection and its prompt management is crucial in 
preventing limb loss
45
.  Almost 50% of diabetic patients with infected ulcer do not 
show the classical signs of infection due to poor blood supply that reduces the 
inflammation and redness and neuropathy that masks the pain
45
.  The aim of 
antimicrobial therapy is to cure the infection and not to heal the wound.  The 
antimicrobial treatment is selected empirically and then according to patients‟ 
response and based on culture and sensitivity reports the antibiotic regimen is 
modified.  In ulcers with mild to moderate infection, oral antibiotics are sufficient.  
Topical antibiotics are also available for local application over the ulcer. 
41 
 
Sometimes infection of the ulcer can spread into the underlying bone causing 
osteomyelitis.  This is treated by resection of all infected and necrosed bone and 
antibiotics that penetrate well into the bone
46
. 
 
Wound care 
Initial management includes cleaning of the wound by removing the necrotic and 
dead tissues and probing the ulcer to check for presence of foreign bodies or to see 
if the bone is exposed
45
. 
Such sharp debridement of the wound enhances the healing of ulcer which includes 
removing of the callous using scalpel and forceps.  Under aseptic precautions the 
pus aspirate should be obtained and sent for culture of micro organism and their 
sensitivity to various antibiotics is tested
45
.  Plain x-ray of foot helps to find out 
presence of foreign body, gas in tissues or presence of osteomyelitis. Blood 
investigations are done to look for complete blood count, leukocyte differentiation, 
basic chemistry panel and ESR (erythrocyte sedimentation rate).  
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Removal of pressure 
Elevated plantar pressure is a causative factor in the development of plantar ulcers 
in diabetic patients with sensory neuropathy
45
.  Repeated trauma and excess 
mechanical load over the foot leads to non healing of diabetic foot ulcer.  
Therefore offloading of the ulcer site helps to prevent repeated trauma and 
facilitates wound healing.  Techniques of removing pressure vary depending on 
various factors like: patient‟s preference and compliance and severity of ulcer  
 
Patient education 
Patent should be educated about good diabetic control, foot care, dangers of 
smoking etc.  All diabetic patients should have an annual foot examination that 
includes assessing for anatomic deformities, skin breaks, nail disorders, loss of 
protective sensation, diminished arterial supply, and improper footwear. 
 
Multidisciplinary Team approach 
A team approach helps in prevention and management of diabetic foot problems.  
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Team member‟s include45: 
1) Physician to educate about glycemic control. 
2) Nurse educator to educate about foot care. 
3) Podiatrist to detect and treat foot lesions 
4) Surgeon for debriding the ulcer 
5) Orthotist for offloading ulcers. 
6) Vascular surgeon for revascularization procedures. 
 
 
Off loading devices 
 
Pressure relief on ulcers and redistributing it to the healthy areas is referred to as 
offloading
47
.  This reduces the trauma to the ulcer site and allows healing. 
Neuropathic ulcers that resisted healing for months to years have healed on use of 
offloading devices
47
. 
Patients should never walk in the same shoes that lead to development of ulcers
48
. 
Bony deformity along with displacement of soft tissue in a neuropathic foot leads 
to elevated plantar pressure causing ulceration and failure to heal
48
.  In a diabetic 
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person, claw toe deformity and charcot‟s neuroarthropathy are the abnormalities 
that can cause disruption of architecture of foot and elevated plantar pressure
48
.  
 
The use of offloading helps to prevent the repetitive trauma associated with 
walking which in turn helps in wound healing
4
.(Amstrong et al 2003) 
Offloading of diabetic foot ulcers can be achieved by using various removable and 
non removable devices
49
. 
 
Methods of offloading include
49
: 
1. Total non weight bearing- bed rest  
2. Total contact cast 
3. Foot casts or boots 
4. Removable walking braces with rocker bottom sole 
5. Half shoes or wedge shoes 
6. Accommodative dressing: felt, foam 
7. Shoe cutouts 
8. Assistive devices like crutches, walker, wheelchair etc. 
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Patient compliance is very important when using an offloading device as it is 
useful only when the patient wears it
50
.  Hence the patient must be educated about 
the importance of the offloading device in order to improve the patient‟s adherence 
to offloading.  Usually neuropathic patients do not wear their offloading device as 
they do not feel any pain.  That is why total contact cast is considered the golden 
standard
50
.  
 
There are various factors that influence a patients desire to wear the device
51
. 
 Instability during the gait. 
 Comfort of the device. 
 Weight 
 Cosmesis 
 Ease of application 
 
Removable walker Casts
52
 
Removable walker casts are easy for the patient and the doctor as it can be 
removed to inspect the wound if infection is present.  They are cost effective and 
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easy to apply.  Removable walker casts are better to use when there is a soft tissue 
or bone infection because it can be removed to inspect the wound.  
Advantages
52
: 
 Easily removed for self inspection 
 Easily removable for local application of therapies. 
 Easy to daily activities 
 Can be used for infected wounds 
 Can be used for superficial wounds 
 
Total Contact Casts (TCC) 
This is the most common method of offloading used by doctors
53
.  This method of 
offloading was first described by Milroy Paul
54
.  TCCs have shown to reduce 
pressure at ulcer sites by 84-92%.  Its healing rates range from 72%-100% over 5-
7weeks
55
.  TCC acts by reducing the pressure by transmitting this pressure along 
the cast wall or to the rear foot.  Hence useful in treating fore foot ulcers
56
. 
Advantages of TCCs
57
: 
 Protects foot from infection 
 Helps in reducing edema 
47 
 
Disadvantages
58
: 
 Technically difficult to apply need experienced persons 
 Time consuming.  
 Improper application causes skin irritation and ulceration 
 Daily wound assessment cannot be done 
 Difficulty in daily activities like bathing without wetting the cast 
 Difficulty in sleeping 
 Affect gait stability. 
 
Contraindications: 
 For wounds with ischemia 
 For infected wounds 
 For wounds with osteomyelitis 
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Half shoes
59
: 
They are designed to decrease the pressure on the fore foot postoperatively. 
Advantage: 
 Removable 
 Easy to apply – inexpensive 
 
 
The key to successful pressure reduction lies in patient‟s adherence than in the 
offloading device that is prescribed.   
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MATERIALS AND METHODS 
 
Source of Data: 
 All patients who have met the inclusion criteria, irrespective of their age or 
sex who come to PSG Hospitals, Coimbatore in the department of surgery/ 
diabetology/medicine with diabetic foot ulcer during the period of February 
2012 to December 2013 were included in the study. 
 
Method of Collection of Data: 
The data for this study was collected from the 30 subjects fulfilling the 
inclusion/exclusion criteria, who came to PSG Hospitals attending Surgery OPD 
for Diabetic foot ulcer care during the study period February 2012 to December 
2013, using a proforma specially designed for the study. 
Sample size: 30 
Study period: February 2012 to December2013 
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Inclusion criteria: 
 Should have Type1 or 2 diabetes mellitus. 
 Should have peripheral neuropathy60 with a palpable foot pulse. 
 Should have plantar ulcers for a period of at least 3weeks. 
 Ulcers should be of Grade 1 according to Wagner‟s Classification61. 
 
Exclusion criteria: 
 Patients with huge ulcers with size >4cm. 
 Patients with more than one ulcer in the same foot. 
 Peripheral vascular disease with ABPI<0.9 
 Presence of clinical signs of infection- erythema, edema, increase local skin 
temp, secretions, fever, gangrene, maggots. 
 Ulcer probing to the bone. 
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Collection of Samples: 
30 random cases were selected from the study group either admitted in surgery 
wards or attending surgery OPD for Diabetic Foot Ulcer management. Cases were 
selected based on inclusion and exclusion criteria included in our study. Consent 
was taken from all the subjects.  
 
Patients were randomized through a computerized randomization schedule into two 
different groups.  In which Group A was off-loaded with a non-removable total 
contact cast, and Group B using Custom Made Shoes. Patients received specific 
instructions on how to manage the off-loading devices.  
A proforma was developed to record the medical history and examination details. 
Medical history was taken for all the subjects.  Details regarding type of diabetes, 
its duration, treatment, compliance and personal habits were recorded.  Patients 
were assessed for peripheral polyneuropathy  which was defined
60 
 as the absence 
of two of five sensory modalities (vibration sensation using the 128-Hz tuning 
fork, light touch, blunt-sharp discrimination, Achilles tendon reflex, and 10-g 
monofilament).  Meticulous examination was done including description of the 
ulcer (site, size, shape and Grade 1 ulcers according to Wagner‟s Classification 
were included) as per the proforma of the study.  Ulcers with hard callous or ulcers 
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containing slough were surgically debrided eliminating all non-viable tissues and 
the entire area of lesion exposed. Ulcers were photographed and traced on to a 
tracing paper or a graph paper and the surface area of the ulcer was measured and 
recorded. Following which the ulcers were dressed and covered with sterile 
dressing before applying the off-loading device.  
Patients in Group A were casted with POP (Plaster of Paris) after positioning a 
layer of protective dressing over the ulcer site to avoid contact with the cast. 
Attention was given in avoiding friction or trauma with bony prominences by 
protecting them with extra layers of cotton. Rubber heals were placed to allow the 
patients to stand and walk. 
 
Patients in Group B were given Custom Made Shoes, adapted according to the 
ulcer site and size and patients foot condition. Forefoot, midfoot and hind foot 
pressure relieving foot wears are prescribed according to ulcer site. All the shoes 
were made by the same podologists. All patients were instructed to wear the device 
at all times during ambulation.  
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Group A patients treated with Total Contact Cast 
 
 
Picture of Total Contact Cast used to off-load ulcers over great toe  
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Picture of Total Contact cast used to off-load ulcers over mid foot 
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Group B patients treated with Custom made Shoes 
Picture showing different types of shoes used to off-load ulcers at 
various sites 
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Follow up 
 
Patients of both the groups were followed up biweekly for upto 90 days or to 
complete reepithelialization of the ulcer. At each checkup, patients in Group A had 
their cast removed. Lesions were debrided if needed, measured, photographed and 
dressed and a new cast was applied. Cast treatment was terminated when there was 
no reduction in wound size or depth during 4 consecutive weeks, when an infection 
greater than grade 2 developed, or when the patient had severe discomfort with the 
cast. These cases are all defined as cast failure
 60
.  The same procedure was carried 
out in Group B patients too. Presences of any adverse events were also recorded 
like discomfort, chafed skin, preulcerative lesion (defined as a non-ulcerative 
lesion related to local pressure in the cast), new ulcers on the affected foot, and 
lower-extremity joint problems and infective complications. 
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Outcome 
 
The primary outcome was the rate of wound healing (complete epithelialization or 
healing at the end of 12weeks). Out of the 33 diabetic patients, 2 failed to complete 
the course of study. Reasons for this included discomfort, instability (two TCC- 
cast failures), or failure to return for follow-up appointments (one custom made 
shoe). 
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Observation and Results 
Study Design: A randomized control study consisting of 32 patients with diabetic 
foot ulcers were undertaken to study the effect of removable and non-removable 
off-loading devices in healing of diabetic foot ulcers and its correlation with 
various clinical features. 
 
Table 1: Age wise distribution of patients in the two study groups 
 
TCC   Shoe   
Age in 
years 
No. of 
patients  Percentage % 
No. of 
patients Percentage % 
30-40 6 37.50 1 7.69 
40-50 4 25.00 5 38.46 
50-60 2 12.50 4 30.77 
60+ 4 25.00 3 23.08 
Total 16 
 
13 
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Graph 1: Age wise distribution in TCC 
 
 
Graph 2: Age wise distribution in Custom-made Shoe 
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As shown in Table 1 & Graph 1 and 2, in the present study the age variation was 
from 34yrs to 68yrs. Majority of the patients were in the age group of 30-40yrs in 
patients with total contact cast which was 37.5% and age group of 40-50yrs in 
patients with custom made shoes which was 38.46%. 
 
Table 2: Gender distribution of patients in the two study groups  
 
TCC   Shoe 
 
Gender 
No. of 
patients  
Percentage 
% 
No. of 
patients 
Percentage 
% 
Male 9 56.25 10 76.92 
Female 7 43.75 3 23.08 
Total 16 
 
13 
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Graph 3 : Gender distribution 
 
 
As shown in Table 2 & Graph 3, majority of the subjects in the 2 groups in the 
present study were Males(56% and 77%) as compared to females (44% and 23%). 
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Table 3: Distribution of sites of ulcers in patients of both study groups  
 
           
 
 
 TCC  Shoe  
Site of Ulcer Number Percentage Number Percentage 
Great toe 5 31.2% 4 30.7% 
Amputated toe 2 12.5% 1 7.6% 
Midfoot 2 12.5% 1 7.6% 
1
st
  metatarsal 2 12.5% 3 23% 
2
nd
 metatarsal 1 6.2% 1 7.6% 
3
rd
 metatarsal - - 1 7.6% 
4
th
  metatarsal 3 18.7% - - 
5
th
 metatarsal 1 6.2% 1 7.6% 
Heel - - 1 7.6% 
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Graph 4 : Distribution of sites of ulcer 
 
 
As shown in Table 3 and Graph 4, majority of the ulcers were seen over the plantar 
aspect of great toe in both the groups. 
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Picture showing various sites of Ulcers 
                
 2
nd
 metatarsal head     1
st
 metatarsal head 
                                    
 4
th
 metatarsal head      Heel 
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Results 
A total of 32 patients were included in the study. Two patients in the TCC group 
and one patient in the custom made shoe group failed to complete the study. Of 
these three dropouts, one patient in TCC group developed pre-ulcerative lesion and 
chafed skin and was not willing for further treatment. The second patient, also in 
the TCC group, developed discomfort in the cast with instability to walk and 
breakage of cast, and hence withdrew from the study. One patient in shoe group 
developed Grade 2 infection which required further debridement and patient lost 
follow up. 
      
 
S.No Adverse Events in TCC Treatment 
1. Chaffing of skin Adequate padding prior to applying 
the cast. 
2. Breakage of cast Cast was reapplied 
3. Discomfort in the cast with 
instability to walk. 
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S.No Adverse Events in Shoe Treatment 
1. Grade 2 infection Minimal debridement and administration 
of oral antibiotics for 7 days 
 
 
Graph 5: Adverse events that occurred in both study groups 
 
 
Of the remaining 29 patients who completed the study, there were 16 patients in 
the TCC group and 13 patients in the custom made shoe group. Some minor 
treatment complications had developed during the study period but none of them 
required termination of treatment or any change in treatment and were improved 
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within the subsequent visits. One patient in the TCC group developed minimal 
chaffing of skin which was relieved by adequate padding prior to applying the cast. 
Another patient had breakage of cast during treatment and cast was reapplied. In 
the shoe group, two patients had developed Grade 2 infection which needed 
minimal debridement and administration of oral antibiotics for 7 days. In both the 
cases the signs of infection had resolved within 1 week and infection did not recur.  
The patients continued their study.  
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The Table 4 below shows characteristics of the patients. 
Table 4: Descriptive characteristics in the two study groups 
  TCC   Shoe   
 
Variables Mean SD Mean SD 
P 
Value 
N 16 
 
13 
  
Age 47.63 10.94 52.00 13.68 0.3466 
Male % 56.25 
 
76.92 
  Duration of Ulcer 
(months) 11.06 9.35 5.62 4.37 0.064 
Duration of DM 
(months) 102.06 70.12 60.54 57.79 0.0982 
Ulcer Size at each 
visit Surface area of Ulcer (cm
2
) 
 Initial visit (0 
Day) 6.82 4.47 5.86 2.57 0.4961 
 After 14 Days 5.08 3.52 5.29 2.75 0.8616 
 After 28 Days 3.60 2.91 4.70 2.96 0.3228 
 After 42 Days 2.96 2.11 3.86 2.72 0.355 
 After 56 Days 2.03 1.76 3.50 2.63 0.1128 
 After 70 Days 1.44 1.52 2.74 2.38 0.1373 
 After 90 Days 1.34 1.33 2.23 2.10 0.4118 
No. of Days for Ulcer 
to Heal 66.63 22.36 83.23 14.46 0.0288 
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There were no significant differences between the two groups in the characteristics 
evaluated like age, sex and duration of diabetes. The healing time was not 
influenced by age, sex or duration of diabetes.   
 
Eleven out of the sixteen patients (68.7%) in TCC group had achieved complete 
healing with 90days of treatment, of which 5 patients  healed between 42 to 70days 
and three out of the thirteen patients (23%) had attained complete healing in 
custom made shoe group at the end of 12 weeks.  
 
Table 4 also shows that the mean number of days for the ulcer to heal in the TCC 
group was 66.63 days whereas in the custom made shoe group it was 83.23 days 
which infers that the mean duration of healing time was less with TCC than with 
custom made shoes. 
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Table 5:Comparative Change in Ulcer Size Between the Two Study Groups 
No. of 
Days TCC 
  
Shoe 
  
 
Ulcer 
Size(cm
2
) 
P 
Value
1
 
P 
Value
2
 
Ulcer 
Size(cm
2
) 
P 
Value
1
 
P 
Value
2
 
0 Day 6.82     5.86     
14 Days 5.08 0.2303 0.2303 5.29 0.5932 0.5932 
28 Days 3.60 0.0218 0.2036 4.70 0.2991 0.6036 
42 Days 2.96 0.008 0.514 3.86 0.0663 0.4578 
56 Days 2.03 0.0012 0.2358 3.50 0.033 0.7385 
70 Days 1.44 0.0008 0.393 2.74 0.0046 0.4674 
90 Days 1.34 0.0154 0.9022 2.23 0.0016 0.5995 
P Value
1
: Comparing each measurement day with the 0 day/baseline 
P Value
2
: Comparing each measurement day with its previous measurement 
 
Table 5 shows that the ulcer surface area decreased from 6.82 cm
2
 - 1.34cm
2
 in 
TCC group and from 5.86 cm
2 
- 2.23 cm
2 
in custom made shoe group. Higher 
proportions of patients were healed by 12weeks in TCC group when compared to 
custom made shoe group. (1.34cm
2
, P value=0.0154, Vs 2.23cm
2
, P value=0.0016). 
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The time taken for the ulcer to heal was directly proportional to the area of the 
ulcer at the time of off-loading. Small ulcers (<3cm) took less than 90days to heal, 
compared to larger ulcers which took 90days or more for the ulcer to heal. 
 
Table 5: Percentage Reduction in Wound Size at Each Visit in the Two Study 
Groups 
 
TCC 
 
Shoe 
 
  
Percentage 
Change in 
Wound Size 
after 
Mean SD Mean SD 
P 
Value 
 
14 Days 28.76 % 14.69 12.22 % 13.55 <0.01  
28 Days 37.81% 22.52 14.26 % 15.64 <0.01  
42 Days 36.13% 12.50 24.08 % 19.37 0.0716  
56 Days 37.17 % 17.28 19.91 % 9.81 <0.01  
70 Days 47.51 % 20.58 26.54 % 16.13 0.0124  
90 Days 56.72 % 16.59 34.14 % 14.43 0.0173  
 
In this table we have calculated the average percentage reduction in size of the 
ulcer at every 2 weeks and the graph below shows the average percentage 
reduction. 
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Graph 6: Comparison of average percentage reduction in ulcer size at each 
visit in the two study groups 
 
 
Group A: TCC, Group B: Shoes 
 
In our study it was also noticed that there was a faster reduction in size of the ulcer 
over the first 4weeks (28days) in patients treated with TCC and that after 4 weeks, 
the ulcer size reduction was almost similar in both the groups.  
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Graph 7: Comparison of wound healing at end of study 
 
 
Group A: TCC, Group B: Shoes 
 
This graph above depicts the ulcer size reduction at the end of study completion 
between patients treated with TCC and custom made shoes. This graph also shows 
that there was a significant reduction in the size of ulcers during the first four 
weeks in patients treated with TCC following which the healing time was almost 
same in both the groups. P value=0.0154 (TCC), P value=0.0016 (Shoe). 
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Pictures Showing Reduction in size of the ulcer over the plantar aspect of 
great toe during treatment with Total Contact Cast 
                   On Day 0                
  After 70 days 
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Pictures Showing complete re-epithelialization of the ulcer over the plantar 
aspect of mid foot after treatment with Total Contact Cast 
 
 
                   
   Picture 1      Picture 2 
 
 Picture 1 showing the size of ulcer after 2 weeks of treatment with Total 
Contact Cast (14
th
 day) 
 Picture 2 showing complete re-epithelialization of the size of ulcer after 
90days of treatment with Total Contact Cast. 
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Pictures Showing Reduction in size of the ulcer over the plantar aspect of 
head of 1
st
 metatarsal during treatment with Custom made Shoes 
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DISCUSSION 
The intent of this study was to compare the ability of removable and irremovable 
devices to effectively offload diabetic neuropathic ulcers.  Two aspects of 
offloading were looked upon: 
1) wound surface areas reduction 
2) number and severity of adverse events 
 
The period of this study was from February 2012 to October 2013. Diabetic 
patients with neuropathic plantar ulcers were included in this study.  These patients 
were randomly divided into two groups, those with the irremovable Total Contact 
Casts (TCC) and those with removable custom made shoes.  Both the study groups 
were explained about the advantages and disadvantages of the treatment.  There 
were various difficulties faced while convincing these patients to get enrolled into 
the study.  Patients planned for TCC were not willing for treatment initially as 
most of these patients were laborers and did not want anything that will restrict 
mobility.  Some patients found difficulty in driving, whereas some patients found 
treatment to be expensive i.e. application of totally 6 POPs.  Patients in custom 
made shoes were explained about the importance of wearing the shoes throughout, 
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but only few patients adhered to these instructions.  Majority of the patients 
developed recurrent trauma or infection of the ulcer which required wound 
debridement, hence leading to further increase in size of these ulcers.  
Comparing the acceptability between the two groups, it was found that patients 
were more easily acceptable with custom made shoes compared to TCC as it had 
these advantages.  
1. Patients were able to enjoy their daily life activities like bathing, sleeping. 
2. Shoes could be used for infected wounds and self inspection of wound was 
possible.  
 
In our study, among the 32 cases of diabetic foot ulcers, who were enrolled, 
29cases were studied, which included 16 patients in TCC group and 13 patients in 
custom made shoe group.  Majority of the subjects in the 2 groups were males 
(56% and 77%) as compared to females (44% and 23%) and were mostly of the 
age group 30-40 years (37.5%) in TCC group and of 40-50yrs (38.46%) in Custom 
made shoe group.  All the patients included in our study were of Diabetes Mellitus 
Type II.  All the patients included in our study had Wagner‟s Grade I diabetic foot 
ulcer.  
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Studies have shown that plantar pressures are highest in the forefoot and less 
towards the rear and medial arch
62
.  In the present study, majority of the 
neuropathic foot ulcers were seen over the plantar aspect more towards the forefoot 
than in other areas of the foot.  Highest percentage of ulcers (31%) were seen over 
the great toe in both TCC and shoe groups.    
Antonella et al (2002) study showed that the forefoot-to-rear foot (F/R) plantar 
pressure ratio is higher in patients with severe peripheral neuropathy
63
.  This 
increased F/R plantar pressure ratio causes the forefoot to be more loaded with 
pressure than rear foot, leading to the development of equinus deformity which is 
the main causative factor for development of diabetic foot ulcers.  His study also 
showed that highest pressures points were commonly seen along the metatarsal 
heads. 
 
Increased biomechanical stress is most crucial in leading to ulceration in patients 
with neuropathic foot ulcers
51
.  In diabetic patients, due to advanced glycation of 
soft tissues, there occurs a functional shortening of Achilles tendon.  This 
combined with motor impairment and rupture of plantar fascia may cause equinus 
deformity or foot drop, and therefore leading to increased pressure load on the 
plantar aspect.  
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Patients with diabetes also have sensory neuropathy with reduced proprioception
35
.  
The ligaments and joint capsule are further stretched and bony structure of foot is 
distorted leading to deformities like claw foot with prominent metatarsal heads.  
These bony changes produce areas of localized high pressure in the sole of the foot 
mainly metatarsal heads, tips of toes and heel
35
.  It would therefore seem 
reasonable to assume that reduction of this stress would promote healing.  Hence, 
offloading of diabetic foot ulcer is the treatment for neuropathic diabetic foot 
ulcers.  
Shaw et al in their study noticed that peak plantar pressures seen in the forefoot 
were remarkably reduced by the use of TCC when compared to Shoes or barefoot 
walking.  TCC achieves forefoot unloading by various mechanisms
62
, two of which 
are: 
1. Almost 30% of weight from the leg is directly transmitted to the cast wall. 
2. TCC removes the load bearing surface from the metatarsal heads by the 
cavity by the soft foam covering the fore foot. 
 
The result of this study shows that the ulcer surface area decreased from 6.82 cm
2
 - 
1.34cm
2
 in TCC group and from 5.86cm
2 
- 2.23cm
2 
in custom made shoe group 
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(TCC: 1.34cm
2
, P value=0.0154, Vs Shoe: 2.23cm
2
, P value=0.0016).  This 
suggests that the non-removable TCCs heal a higher proportion of wounds by 12 
weeks compared to removable Custom made shoes.  Hence, we can say that the 
success of offloading is strictly related to the non removability of the device used.  
In this present study it was also noticed that there was a faster reduction in size of 
the ulcer over the first 4weeks (28days) in patients treated with TCC and that after 
4 weeks, the ulcer size reduction was almost similar in both the groups.  
 
Hence, it could be suggested that diabetic patients with plantar neuropathic ulcers 
could start their off-loading with TCC and then switched over to custom made 
shoes, if they wished. 
 
Earlier studies by, Armstrong et al (2005) have shown that the rate of healing of 
neuropathic diabetic ulcers at 12weeks is greater than 80% in patients treated with 
irremovable devices, while it reduced to less than 60% in patients treated with 
removable devices
51
.  Since diabetic neuropathic ulcer patients have an insensate 
foot and do not feel the pain, they tend to walk without the removable shoe which 
adds to the lack of compliance.  A study by Armstrong et al (2003) showed that 
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there was an increase in the number of footsteps and activities in patients with 
removable shoes off than footsteps with removable shoes on
50
.  This revealed that 
patients were incompliant with removable device.  Hence non removable casts are 
superior over removable devices
50
 because of the fact that patients cannot remove 
the TCC and they take less active when using it.  Armstrong et al (2003) study also 
noticed that though the patients with removable shoes were advised to wear the 
shoes continuously, patients wore them only for 28% of their footsteps
52
.  In our 
study, most of the patients in the custom made shoes group, admitted to the fact 
that they wore the shoes only during outdoor activities.  It therefore emphasizes the 
point that effective counseling is necessary prior to starting the treatment with 
custom made shoes. 
It was also seen that patients with TCC had reduced repetitive stress to the ulcer as 
it was completely covered.  This was not the case with custom made shoes, 
because the wounds were open.  A few patients developed wound infection, which 
required debridement, thereby further leading to increase in size of ulcer and 
increased healing time.  This in turn explains the success of TCC over Custom 
made shoes. 
Apart from the ability to mitigate pressure, TCCs have several advantages.  TCCs 
due to its complete coverage protect the wound from infection.  TCCs help to 
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control edema
57
.  The most important point for TCC is its ability to “force 
compliance” in patients.  Patients using TCC are forced to use the cast all 
throughout as the device cannot be removed easily without the clinician‟s orders.  
Thus TCC is indeed the better choice to offload neuropathic diabetic plantar ulcers. 
There were also several limitations of  TCC
64
 that were reported, such as new 
ulcers may develop in the cast at areas of friction of skin with the cast, and the 
inability of patients and clinicians to assess wound daily.  All clinicians do not 
have an experienced technician to apply a cast correctly as improper application 
can cause skin irritation or ulceration.  Mobility of patients is impaired which 
affects the daily activities like bathing and sleeping.  Costs of treatment with TCC 
may be high as compared to Custom made shoes which are one time expenditure
64
.  
TCCs are contraindicated in patients with soft tissue infections. 
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Conclusion 
 
The main treatment of diabetic neuropathic, non-infected, non-ischemic ulcers is 
proper debridement and pressure reduction over the ulcer. 
In conclusion, this study suggests that based on the different offloading devices 
selected there is a significant difference in healing of diabetic foot ulcers. 
TCCs are gold standard in offloading diabetic foot ulcers with high proportion of 
healing rates of 68.7%. Eleven out of the sixteen patients achieved complete 
healing with 90days of treatment, of which 5 patients healed between 42 to 70days 
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Proforma 
Patient  Identication: 
Date:                              Time:                               Height:                      Weight:  
 
1. Describe the reason for the visit? 
2. History of present illness / wound status: 
 When the wound was first noticed? 
 How did the wound start? 
 How do you clean your wound? 
 What do you use for a dressing change? 
 How often do you change your dressing? 
 What previous treatments have you had for the wound? 
 Did any previous treatments help your wound? 
 Does the wound cause you pain? 
 If so describe  the pain on a scale: at its worst______ at its best_______ 
 When you have pain how long does it last? 
 When does the pain occur most often? 
 What makes the pain worse? 
 What makes the pain better? 
 Do you have any other symptom with the pain? 
 
1. Medical history: ______________________________________________ 
 
 
104 
 
2. Past hospitalizations 
Date                               Reason for hospitalization 
__________                 ____________________________________________ 
__________                 ____________________________________________ 
 
 
3. Current medications: 
Medication                  Dose/How often 
__________                 ____________________________________________ 
__________                 ____________________________________________ 
__________                 ____________________________________________ 
 
4. Allergies                                        Reaction: 
__________                 ____________________________________________ 
__________                 ____________________________________________ 
__________                 ____________________________________________ 
__________                 ____________________________________________ 
Allergy to rubber or latex containing products? 
 
5. Habits: 
Tobacco use:    Type____How much_______how many years_______Quit? 
Alcohol use:    Type_____How much______how many years________Quit? 
Illicit drug use:  Type_______ How much______how many years______Quit? 
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6. Diet:  Special diet/ diet restrictions: 
____________________________________________ 
 
 
7. Family history: 
   Diabetes                Heart problem           Stroke             Cancer             Leg ulcer  
 
 
8. Social history: 
 Marital status _________________________________________ 
 Who do you live with?___________________________________ 
 Occupation?__________________________________________ 
 Who changes your dressing?_____________________________ 
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EXAMINATION at each visit: 
Any new complaints:_________________________________________________ 
Wound assessment: 
 Location :   
 Wound etiology: 
 Size(cm):   L____  x   B_____   
 Photo: 
 Painful:         Yes           No 
 Wound color: 
 Fibrous tissue:     
 Granulation tissue 
 Necrotic tissue 
 Margins:           wnl               macerated             
 Edema :            No                 Yes 
 Erythema:        No                 Yes 
 Odour: 
 Drainage: 
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 Pulses: 
Dorsalis pedis:  R:____, L:______ 
Popliteal :          R:____, L:______ 
Femoral:            R:____, L:______ 
 Deep tendon reflexes: 
 Sensations:         vibratory sensation                 proprioception 
 Lymphatics: 
 Labs / Imaging results: 
 
Assessment: 
________________________________________________________________ 
 
 
Treatment Plan:  
 Wound assessed:  Yes (  )      No (  ) 
 Wound cleaned:   Yes (   )  No (  ) 
 Patient/family education: Yes (   )   No (   ) 
 Sharp debridement: Partial thickness (  ) 
                                      Full thickness (  ) 
 Anaesthesia type:   Yes (  )    No (  ) 
 Neuropathic :  Yes (  )     No (  ) 
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 Dressings /  cast / device /  shoe gear: 
_____________________________________________________________ 
 
 
 Wound care orders:  
_____________________________________________________________ 
 
 
 Procedures/ diagnostic tests ordered: 
____________________________________________________________ 
 
 
 Others: 
_____________________________________________________________ 
 
 
 Treatment: 
_____________________________________________________________ 
 
 Next visit:        1week           2week            3week           4week         
 
 Others:  _____________________________________________________ 
 
 
Physician‟s signature and date:  
_________________________________________________________________ 
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Master chart TCC Group 
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Master chart Shoe Group 
 
 
